Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,688
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition

Saleh A. Alanazia Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;b Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi ArabiaView further author information
,
Gamaleldin I. Harisaa Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;c Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;d Department of Biochemistry, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, EgyptCorrespondence[email protected]
View further author information
,
Mohamed M. Badranc Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;e Department of Pharmaceutics, College of Pharmacy, Al-Azhar University, Nasr City Cairo, EgyptView further author information
,
Fars K. Alanazia Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Ehab Elzayata Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;c Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Abdullah H. Alomranic Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;f Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Osaid T. Al Meanazela Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;g Michael Sayegh Faculty of Pharmacy, Aqaba University of Technology, Aqaba, JordanView further author information
&
Ahmed T. Al Meanazelh Prince Naif for the Health Research Center, King Saud University, Riyadh, Saudi ArabiaView further author information
 show all
Pages 914-926 | Received 07 Jan 2021, Accepted 19 Feb 2021, Published online: 08 Mar 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yitong Li, Ruihang Zhang, Zhen Xu & Zhicheng Wang. (2022) Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine 17, pages 909-925.
Read now

Articles from other publishers (5)

Abdelrahman Y. Sherif, Gamaleldin I. Harisa & Fars K. Alanazi. (2024) The Chimera of TPGS and Nanoscale Lipid Carriers as Lymphatic Drug Delivery Vehicles to Fight Metastatic Cancers. Current Drug Delivery 21:4, pages 525-543.
Crossref
Gamaleldin I. Harisa, Saleh A. Alanazi, Mohamed M. Badran, Abdelrahman Y. Sherif, Saeed A. AlQahtani & Fars K. Alanazi. (2023) Tyloxapol and nanoliposomes induce selective delivery of 5‐fluorouracil into hepatic tissues via VLDL/LDL‐mediated pathway. European Journal of Lipid Science and Technology 126:1.
Crossref
Abdelrahman Y. Sherif, Gamaleldin I. Harisa & Fars K. Alanazi. (2023) SLN Mediate Active Delivery of Gefitinib into A549 Cell Line: Optimization, Biosafety and Cytotoxicity Studies. Drug Delivery Letters 13:2, pages 133-150.
Crossref
Gamaleldin I. Harisa, Abdelrahman Y. Sherif, Fars K. Alanazi, Essam A. Ali, Gamal A. Omran, Fahd A. Nasr, Sabry M. Attia & Ali S. Alqahtani. (2023) TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies. Colloids and Surfaces B: Biointerfaces 223, pages 113148.
Crossref
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi & Mahmoud Teaima. (2022) Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 20:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.